Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp. Post published:February 23, 2021 Post category:Press Release
PharmaTher Announces Research Collaboration with Terasaki Institute for Novel Microneedle Delivery of Psychedelic Pharmaceuticals Post published:February 23, 2021 Post category:Press Release
Bright Minds Biosciences Inc. Announces Marketed Public Offering Post published:February 22, 2021 Post category:Press Release
Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF Post published:February 22, 2021 Post category:Press Release
Beckley Psytech appoints ex-pharma CEO as Chief Operating Officer Post published:February 22, 2021 Post category:Press Release
Awakn Chief Medical Officer, Dr. Ben Sessa, Announces Results of the World’s First ‘MDMA in Alcohol Use Disorder’ Clinical Trial Post published:February 22, 2021 Post category:Press Release
Mind Cure Announces Addition of Global Technology Leader Robert C. Hill to Board of Directors Post published:February 22, 2021 Post category:Press Release
Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study Post published:February 22, 2021 Post category:Press Release
Aion Therapeutic Announces Closing of Non-Brokered Private Placement Post published:February 22, 2021 Post category:Press Release
PsyBio Completes Reverse Take-Over Transaction Post published:February 19, 2021 Post category:Press Release